source
- Biotronik Neuro snaps up spinal cord stimulation portfolio from Soin Neuroscience for next-gen pain projectBiotronik Neuro has acquired a portfolio of spinal cord stimulation patents from the Ohio-based medical device company Soin Neuroscience as the pair look to create “a next-generation spinal cord st…Fierce Biotech · 14d ago↗ source
- Experts: Ending adequate provision would shut down prescription drug adsThe US Food and Drug Administration’s (FDA) plans to eliminate adequate provision in direct-to-consumer (DTC) prescription drug ads could result in a de facto ban on drug advertising due to the hig…raps · 14d ago↗ source
- Industry wants more clarity on NGS for assessing gene therapy safetyThe pharmaceutical industry has largely endorsed the US Food and Drug Administration's (FDA) guidance on next-generation sequencing (NGS) for assessing the safety of human gene therapy products. Ho…